Warren Hogarth
Co-Founder, CEO @ Tilt (formerly Empower)
San Francisco, United States
Warren Hogarth is a venture capitalist at Prior to joining Sequoia Capital in 2008, Warren completed his PhD in Chemical Engineering, where he developed fuel cell technology. During this time, he was a visiting Fulbright Scholar toPrinceton University and a Guest Scientist at Germany's Fraunhofer Institute for Solar Energy Systems. Warren has an MBA from Harvard Business School and a PhD in Chemical Engineering from the University of Queensland.
- Total investments:
- 24
- Last investment:
- Lead investor:
- 25%
Last updated:
For AI agents: llms.txt
Industries Warren Hogarth invests in
Stages Warren Hogarth invests in
Countries Warren Hogarth invests in
Round sizes
Round size
- Seed
- $2.5M–$13M
- Series B
- $11M–$30M
- Series C
- $13M–$55M
Investment Focus
Industry
- FinTech 4 (17%)
- Financial Services 4 (17%)
- Finance 3 (13%)
- Energy 2 (8%)
- Health Care 2 (8%)
Stage
- Seed 4 (17%)
- Series B 4 (17%)
- Series C 4 (17%)
- Series A 3 (13%)
- Series D 2 (8%)
Country
- United States 8 (33%)
- Australia 2 (8%)
- Pakistan 1 (4%)
- New Zealand 1 (4%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Marloo
|
Marloo is an AI-assistant that empowers financial advisers to focus on building client relationships, instead of paperwork. | $2.7M / Pre-Seed / Sep 08, 2025 | |
NayaPay
|
NayaPay is a digital platform that provides online transaction and banking services. | $13M / Seed / Feb 23, 2022 | |
Fable Food
|
Fable Food Co is a meat alternative company known for its meaty food made from mushrooms, which are clean label, minimally processed and made with all natural plant-based ingredients. The products are available in Harris Farm Markets, Coles and Woolworths, as well as Marley Spoon and Dinnerly meal delivery kits, and in various restaurant menusaround Australia, Singapore, and the UK. | $4.8M / Seed / Aug 12, 2021 | |
Great Question
|
Great Question is a customer research platform designed to automate research tasks and gain consumer insights. Great Question allows its users to recruit participants, run their preferred methods, and synthesize and share their findings all in one collaborative platform. | $2.5M / Seed / Jul 14, 2021 | |
Celo
|
Celo is an open platform that makes financial tools accessible to anyone with a mobile phone. Its mission is to build a monetary system that creates the conditions of prosperity for all.The Celo ecosystem includes a decentralized, proof-of-stake blockchain technology stack (Celo Platform), a native asset (CELO), a stablecoin (cUSD) and the CeloAlliance for Prosperity, with over 100 organizations around the world, including Andreesen Horowitz, Anchorage, Coinbase, GSMA, Mercy Corps, Grameen Foundation, Prosegur, Abra, and cLabs, a service organization dedicated to growing and developing the Celo ecosystem. | $6.5M / Jun 25, 2018 | |
Comprehend Systems
|
Comprehend provides a suite of cloud applications and consulting services that improve the clinical trial process. Their solutions deliver actionable risk and performance insights across studies, systems, sites, and vendors. It was founded in 2010 and headquartered in Redwood City, California. | $15M / Series C / Feb 06, 2017 | |
Sunbit
|
Sunbit is a buy now, pay later technology of service providers and retailers fulfilling the needs of thousands of local communities. Sunbit eases the stress of buying everyday things by offering access to fast, fair, and transparent payment options to people across the credit spectrum. Sunbit technology is offered in-store and online through nearly7,300 locations, including 1 in 4 auto dealership service centers, optical practices, dentist offices, and specialty health care services. Payment options through Sunbit can be found at these establishments www.sunbit.com/shop-directoryLoans are made by Transportation Alliance Bank, Inc., dba TAB Bank, which determines qualifications for and terms of credit. | $2.9M / Seed / Sep 13, 2016 | |
Assurerx Health
|
Assurex Health is a personalized medicine company dedicated to helping clinicians determine the right medication for individual patients with medical conditions. Assurex Health’s proprietary Genesight® technology is based on pharmacogenomics – the study of the genetic factors that influence an individual’s response to drug treatments – as well asevidence-based medicine and clinical pharmacology. | $15M / Series D / Dec 21, 2015 | |
Guardant Health
|
Guardant Health is committed to positively and significantly impacting patient health through technology breakthroughs that pointedly address long-standing unmet needs in oncology. Guardant is backed by Sequoia Capital, led by a seasoned management team comprising thought leaders and successful serial entrepreneurs in next-generation sequencing andrare-cell diagnostics and is closely advised by an oncologist-led medical steering committee from leading cancer centers across North America and abroad. | $50M / Series C / Feb 03, 2015 | |
|
Assurerx Health
|
Assurex Health is a personalized medicine company dedicated to helping clinicians determine the right medication for individual patients with medical conditions. Assurex Health’s proprietary Genesight® technology is based on pharmacogenomics – the study of the genetic factors that influence an individual’s response to drug treatments – as well asevidence-based medicine and clinical pharmacology. | $37.4M / Series D / Dec 23, 2014 | |
| See all 24 investments → | |||
Co-Investors
About Tilt (formerly Empower)
Founded by former Sequoia Capital partner and entrepreneur Warren Hogarth, Empower is building a personal financial assistant and digital bank for millennials. Today, the interests of consumers and banks is fundamentally misaligned: banks earn the most when people pay maximum fees, earn little to no interest, and are locked into the highestinterest rates. Empower has built an AI powered financial assistant that works 24/7 to help consumers improve their financial lives and is launching a new kind of bank for tech savvy young professionals that are hustling to get ahead.
Tilt (formerly Empower) Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Justin Ammerlaan
Co-Founder, CTO
|
|||
Mac Muir
Head of Operations
|
|||
Sam Elliott
Design Lead
|
|||
Stephanie Lin
CMO
|
|||
|
Warren Hogarth
Co-Founder, CEO
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Warren Hogarth invest in?
Warren Hogarth invests primarily in FinTech, Financial Services and Finance startups, most often at Seed and Series B stage. Most of the 24 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Warren Hogarth's check size?
Warren Hogarth typically joins rounds of $2.5M–$13M at Seed, $11M–$30M at Series B and $13M–$55M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Warren Hogarth participates in.
When did Warren Hogarth last invest?
The most recent investment recorded for Warren Hogarth closed in Sep 2025. Shizune tracks 24 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
